Sign up for free.
Infektio Research is a research company specializing in clinical infectious medicine, based in Frankfurt am Main, that conducts scientific studies and research projects related to infectiological and travel medicine issues.[1][10] The focus of the work is on Phase II/III clinical trials as well as epidemiological-clinical research projects in cooperation with national and international research groups and research-based pharmaceutical companies.[1]
The range of services primarily includes the development of new treatment approaches for HIV, the improvement of drug therapy options for chronic viral hepatitis such as Hepatitis B and C, as well as studies on the prevention of HIV infections.[1] In addition, Infektio Research is involved in new therapeutic approaches for sexually transmitted diseases, further treatment options for Herpes infections and participation in vaccine studies.[1][2] The company also supports studies on vaccinations against as well as diagnostics related to .[2]
The mission of the company is to contribute to the further development of more effective and better tolerated therapies in the field of infectious medicine through clinical research.[1] Infektio Research combines scientific excellence with the practical experience of an infectious disease practice to closely link research and care.[1] The recognizable values include scientific diligence, international cooperation and a clear focus on patient-relevant medical innovations.[1]
According to the available information, the website makes no specific statements about sustainability goals or formal sustainability initiatives.[1][2][8] However, as an indirect contribution to sustainability, the research into better prevention and therapy concepts in the field of infectious diseases should be emphasized, as such developments can relieve health systems and reduce the burden of disease in the long term.[1][2]
Overall, Infektio Research positions itself as a specialized partner for clinical infection research, contributing to medical development in central areas of infection with scientific depth, a broad range of studies and international networking.[1][2]
